The exchange is a cosmetic restructuring — shares retired but immediately replaced by exercisable warrants. No cash infusion, no change to economic exposure. Monitor for any additional exchanges under the agreement and for any subsequent capital raise that would add real dilution.
Price Chart
Executive Summary
Maze Therapeutics entered into an exchange agreement with Frazier Life Sciences funds to exchange 2,776,007 shares of common stock for pre-funded warrants with a $0.001 exercise price. The exchange reduces outstanding shares from ~56.7M to 53,931,889 (a ~5.1% reduction), but the warrants are immediately exercisable, restoring full dilution. The transaction is a capital structure restructuring with no net change to potential share count, executed via a Section 3(a)(9) exchange without new cash to the company.
Key Facts
- Maze exchanged 2,776,007 common shares for pre-funded warrants exercisable at $0.001/share
- Post-exchange outstanding shares: 53,931,889 (down from ~56.7M)
- Warrants have a 9.99% beneficial ownership blocker
- Exchange executed under Section 3(a)(9) exemption — no registration, no commissions
- Frazier Life Sciences Public Fund exchanged 2,617,703 of the 2,776,007 total shares
- Additional exchanges possible with company consent
Financial Impact
No new capital raised; net dilution unchanged as warrants replace shares 1:1. Outstanding share count reduced by ~5.1% but fully offset by exercisable warrants.
Risk Factors
- Warrant exercise could add selling pressure if holders monetize positions
- Additional exchanges at company's discretion could further restructure the cap table
- No new capital raised — cash runway unchanged
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-424067 |
| Document: d445364d8k.htm | 0001193125-26-424067 |
| Document: 0001193125-26-424067-index-headers.html | 0001193125-26-424067 |
| Document: 0001193125-26-424067-index.html | 0001193125-26-424067 |
| Document: 0001193125-26-424067.txt | 0001193125-26-424067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 8-K | $29.70 | awaiting T+5 | — | $31.07 (+4.61%) |
Oct 2, 2026 24d ago | Insider Cluster | $26.43 $27.70 | ▼ −4.81% | ▼ −4.38% | $31.07 (−17.56%) |
Oct 1, 2026 25d ago | 144 | $26.43 $27.11 | ▲ +2.57% | ▲ +1.41% | $31.07 (+17.56%) |
Sep 8, 2026 6w ago | Insider Cluster | $24.58 $23.92 | ▲ +2.71% | ▲ +1.61% | $31.07 (−26.40%) |
Sep 4, 2026 7w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $31.07 (+17.82%) |
Sep 4, 2026 7w ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $31.07 (+17.82%) |
Sep 3, 2026 7w ago | Insider Cluster | $26.21 $24.67 | ▼ −5.88% | ▼ −4.67% | $31.07 (+18.54%) |
Sep 2, 2026 7w ago | 144 | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $31.07 (+20.10%) |
Sep 1, 2026 7w ago | 144 | $26.72 $24.82 | ▼ −7.11% | ▼ −6.15% | $31.07 (+16.28%) |
Aug 17, 2026 9w ago | 3 | $29.13 $30.42 | ▲ +4.43% | ▲ +4.63% | $31.07 (+6.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers